Indian Generic Players Begin Price War Over Generic Empagliflozin Launches

The Launches Follow The Expiry of Boehringer’s Patents For The Blockbuster Drug

Eyeing the lucrative opportunity, three Indian players have launched their generic versions of Boehringer’s anti-diabetes drug Jardiance in their domestic market.

India
Pharma In India Working With Stakeholders To Maintain Supplies • Source: Shutterstock

More from Generics

More from Generics Bulletin